Rachel M.A. Linger

1.5k citations
12 papers · 1.2k indexed · 1 hit paper · h-index 8
Topics
Phagocytosis and Immune Regulation (5 papers)Cancer therapeutics and mechanisms (1 paper)Technology Adoption and User Behaviour (1 paper)
Partner nations
United States

In The Last Decade

Rachel M.A. Linger

11 papers receiving 1.2k citations

Hit Papers

TAM Receptor Tyrosine Kinases: Biologic Functions, Signal...20082026201420202008100200300400500

Peers

Rachel M.A. Linger
Comparison fields: 5 of 78
  • Immunology 796
  • Molecular Biology 359
  • Oncology 254
  • Cellular and Molecular Neuroscience 165
  • Physiology 154
Replace Peiyuan Lu with:
Peiyuan Lu China
Denise Tischner Germany
Brian Niland United States
Abhik Ray Chaudhury United States
Jean Kloss United States
Sherri L. Rankin United States
Chung Kwon Kim South Korea
Virginie Vives France
Ingrid Teige Sweden
Ernest Smith United States
Rachel M.A. Linger relative to Peiyuan Lu China Peiyuan Lu's profile →
Citations per field
00.5×1.5×2.1×
Peiyuan Lu · 1×
Citations per year

Countries citing papers authored by Rachel M.A. Linger

Since Specialization
Citations

This map shows the geographic impact of Rachel M.A. Linger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel M.A. Linger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel M.A. Linger more than expected).

Fields of papers citing papers by Rachel M.A. Linger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel M.A. Linger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel M.A. Linger. The network helps show where Rachel M.A. Linger may publish in the future.

Co-authorship network of co-authors of Rachel M.A. Linger

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel M.A. Linger. A scholar is included among the top collaborators of Rachel M.A. Linger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel M.A. Linger. Rachel M.A. Linger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 2
5 29
6 47
7 170
8 29
9 31
10 133
11 161
12
TAM Receptor Tyrosine Kinases: Biologic Functions, Signaling, and Potential Therapeutic Targeting in Human Cancerbreakdown →
577

About Rachel M.A. Linger

Rachel M.A. Linger is a scholar working on Immunology, Information Systems and Management and Emergency Medical Services, having authored 12 papers that have together received 1.2k indexed citations. Recurring topics across this work include Phagocytosis and Immune Regulation (5 papers), Cancer therapeutics and mechanisms (1 paper) and Technology Adoption and User Behaviour (1 paper). The work is most often cited by research in Immunology (796 citations), Oncology (254 citations) and Cellular and Molecular Neuroscience (165 citations). Rachel M.A. Linger has collaborated with scholars based in United States. Frequent co-authors include Douglas K. Graham, Amy K. Keating, H. Shelton Earp, Kurtis D. Davies, Ronald K. Freund, Susan Goebel-Goody, Michael Browning, Deborah DeRyckere, Susan Sather and Christopher T. Cummings. Their work appears in journals such as Blood, PLoS ONE and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026